GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Mar 18, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-repurchase, transaction-in-own-shares
Related Tickers: GSK
TL;DR
GSK is buying back its own stock, signaling confidence.
AI Summary
GSK plc announced on March 18, 2025, that it has purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for many public companies.
Key Players & Entities
- GSK plc (company) — Filer of the report
- Citigroup Global Markets Limited (company) — Corporate stockbroker executing share purchases
- March 2025 (date) — Reporting period for the transaction
- March 18, 2025 (date) — Date of the announcement and transaction
FAQ
What specific number of GSK plc ordinary shares were purchased?
The filing states that a 'number' of ordinary shares were purchased but does not specify the exact quantity.
What was the total dollar amount spent on the share repurchases?
The filing does not disclose the total dollar amount of the share repurchases.
Through which entity did GSK plc conduct these share purchases?
GSK plc acted through its corporate stockbroker, Citigroup Global Markets Limited.
What is the par value of GSK plc's ordinary shares?
The ordinary shares have a par value of 31 1/4 pence each.
When was this transaction in own shares announced?
The transaction was announced on March 18, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 18, 2025 regarding GSK plc (GLAXF).